chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise, Motor dysfunction, Organ donor, Pain in extremity, Platelet count normal
Clinical narrative: Intracerebral hemorrhage while skiing on 2/19/21. Progressed to unresponsiveness. Declared brain dead and removed from life support. 2/20/21
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Respiration abnormal, Snoring, Trismus, Unresponsive to stimuli
Clinical narrative: Intracerebral hemorrhage while skiing on 2/19/21. Progressed to unresponsiveness. Declared brain dead and removed from life support. 2/20/21
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arteriogram carotid abnormal, Brain death, Carotid artery stenosis, Cerebral haemorrhage, Computerised tomogram head abnormal
Clinical narrative: Intracerebral hemorrhage while skiing on 2/19/21. Progressed to unresponsiveness. Declared brain dead and removed from life support. 2/20/21
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Intraventricular haemorrhage, Thalamic infarction, Unresponsive to stimuli, Withdrawal of life support
Clinical narrative: Intracerebral hemorrhage while skiing on 2/19/21. Progressed to unresponsiveness. Declared brain dead and removed from life support. 2/20/21
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Patient developed pain and tingling in skin of her leg about 2-3 days after Pfizer Covid vaccine. By 7/24 (the day of reporting) she had developed blisters and still having pain, suspecting shingles.  She has had shingles in the leg previously.  She will be contacting her doctor on Monday to address. At this point she is not overly distressed; she has had this before and feels she is ok to wait to talk to her doctor on Monday.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blister, Pain in extremity, Paraesthesia
Clinical narrative: Patient developed pain and tingling in skin of her leg about 2-3 days after Pfizer Covid vaccine. By 7/24 (the day of reporting) she had developed blisters and still having pain, suspecting shingles.  She has had shingles in the leg previously.  She will be contacting her doctor on Monday to address. At this point she is not overly distressed; she has had this before and feels she is ok to wait to talk to her doctor on Monday.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Incorrect dose administered
Clinical narrative: RECEIVED DOSE OF 0.3 MLS OF VACCINE INADVERTENTLY; This spontaneous report received from a pharmacist concerned a 53 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included type 2 diabetes, and multiple sclerosis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821281 and expiry: 06-SEP-2021) 0.3 ml, administered on 19-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 19-JUL-2021, the subject experienced received dose of 0.3 mls of vaccine inadvertently. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of received dose of 0.3 mls of vaccine inadvertently was not reported. This report was non-serious.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Underdose
Clinical narrative: RECEIVED DOSE OF 0.3 MLS OF VACCINE INADVERTENTLY; This spontaneous report received from a pharmacist concerned a 53 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included type 2 diabetes, and multiple sclerosis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821281 and expiry: 06-SEP-2021) 0.3 ml, administered on 19-JUL-2021 for prophylactic vaccination. No concomitant medications were reported. On 19-JUL-2021, the subject experienced received dose of 0.3 mls of vaccine inadvertently. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of received dose of 0.3 mls of vaccine inadvertently was not reported. This report was non-serious.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aphasia, Asthenia, Blood test, Body temperature increased, Chills
Clinical narrative: HALLUCINATING; MUSCLE CRAMPS; FEVER 102; TINGLING; SHOOTING/ EXCRUCIATING PAIN; IN BED FOR 2 DAYS; This spontaneous report received from a patient concerned a 35 year old female of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201a21a, and expiry: UNKNOWN) dose was not reported, 1 total, administered on 09-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-JUL-2021, after eight hours of vaccination the patient started experiencing fever 102 F, muscle cramps, chills, hallucinating, and was in bed for 2 days. The patient took warm cloth on forehead to reduce the fever. On an unspecified date in JUL-2021, the patient also experienced tingling and had shooting pain and also had a bad headache. On an unspecified date in JUL-2021, the patient went to ER (emergency room), was hospitalized and ordered MRI (magnetic resonance imaging).The patient was hospitalized for 4 days. It was reported that since the patient had a bad headache so preferred to file the complaint online and also stated not to call health case professional due to pending lab results. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from in bed for 2 days on 11-JUL-2021, had not recovered from fever 102, and shooting pain, and the outcome of muscle cramps, hallucinating and tingling was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20210743704-COVID-19 VACCINE AD26.COV2.S-Hallucinating,Muscle cramps,Tingling,Shooting/Excruciating pain. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).  V0:20210743704-COVID-19 VACCINE AD26.COV2.S-Fever 102. This event(s) is labeled per agency and is therefore considered potentially related.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling cold, Gait disturbance, Headache, Hypoaesthesia, Impaired work ability
Clinical narrative: HALLUCINATING; MUSCLE CRAMPS; FEVER 102; TINGLING; SHOOTING/ EXCRUCIATING PAIN; IN BED FOR 2 DAYS; This spontaneous report received from a patient concerned a 35 year old female of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201a21a, and expiry: UNKNOWN) dose was not reported, 1 total, administered on 09-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-JUL-2021, after eight hours of vaccination the patient started experiencing fever 102 F, muscle cramps, chills, hallucinating, and was in bed for 2 days. The patient took warm cloth on forehead to reduce the fever. On an unspecified date in JUL-2021, the patient also experienced tingling and had shooting pain and also had a bad headache. On an unspecified date in JUL-2021, the patient went to ER (emergency room), was hospitalized and ordered MRI (magnetic resonance imaging).The patient was hospitalized for 4 days. It was reported that since the patient had a bad headache so preferred to file the complaint online and also stated not to call health case professional due to pending lab results. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from in bed for 2 days on 11-JUL-2021, had not recovered from fever 102, and shooting pain, and the outcome of muscle cramps, hallucinating and tingling was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20210743704-COVID-19 VACCINE AD26.COV2.S-Hallucinating,Muscle cramps,Tingling,Shooting/Excruciating pain. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).  V0:20210743704-COVID-19 VACCINE AD26.COV2.S-Fever 102. This event(s) is labeled per agency and is therefore considered potentially related.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lumbar puncture, Magnetic resonance imaging head, Magnetic resonance imaging neck, Myalgia, Paraesthesia
Clinical narrative: HALLUCINATING; MUSCLE CRAMPS; FEVER 102; TINGLING; SHOOTING/ EXCRUCIATING PAIN; IN BED FOR 2 DAYS; This spontaneous report received from a patient concerned a 35 year old female of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201a21a, and expiry: UNKNOWN) dose was not reported, 1 total, administered on 09-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-JUL-2021, after eight hours of vaccination the patient started experiencing fever 102 F, muscle cramps, chills, hallucinating, and was in bed for 2 days. The patient took warm cloth on forehead to reduce the fever. On an unspecified date in JUL-2021, the patient also experienced tingling and had shooting pain and also had a bad headache. On an unspecified date in JUL-2021, the patient went to ER (emergency room), was hospitalized and ordered MRI (magnetic resonance imaging).The patient was hospitalized for 4 days. It was reported that since the patient had a bad headache so preferred to file the complaint online and also stated not to call health case professional due to pending lab results. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from in bed for 2 days on 11-JUL-2021, had not recovered from fever 102, and shooting pain, and the outcome of muscle cramps, hallucinating and tingling was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20210743704-COVID-19 VACCINE AD26.COV2.S-Hallucinating,Muscle cramps,Tingling,Shooting/Excruciating pain. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).  V0:20210743704-COVID-19 VACCINE AD26.COV2.S-Fever 102. This event(s) is labeled per agency and is therefore considered potentially related.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Scan, Scan with contrast, X-ray
Clinical narrative: HALLUCINATING; MUSCLE CRAMPS; FEVER 102; TINGLING; SHOOTING/ EXCRUCIATING PAIN; IN BED FOR 2 DAYS; This spontaneous report received from a patient concerned a 35 year old female of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201a21a, and expiry: UNKNOWN) dose was not reported, 1 total, administered on 09-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-JUL-2021, after eight hours of vaccination the patient started experiencing fever 102 F, muscle cramps, chills, hallucinating, and was in bed for 2 days. The patient took warm cloth on forehead to reduce the fever. On an unspecified date in JUL-2021, the patient also experienced tingling and had shooting pain and also had a bad headache. On an unspecified date in JUL-2021, the patient went to ER (emergency room), was hospitalized and ordered MRI (magnetic resonance imaging).The patient was hospitalized for 4 days. It was reported that since the patient had a bad headache so preferred to file the complaint online and also stated not to call health case professional due to pending lab results. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from in bed for 2 days on 11-JUL-2021, had not recovered from fever 102, and shooting pain, and the outcome of muscle cramps, hallucinating and tingling was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20210743704-COVID-19 VACCINE AD26.COV2.S-Hallucinating,Muscle cramps,Tingling,Shooting/Excruciating pain. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).  V0:20210743704-COVID-19 VACCINE AD26.COV2.S-Fever 102. This event(s) is labeled per agency and is therefore considered potentially related.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Bedridden, Body temperature, Hallucination, Muscle spasms, Pain
Clinical narrative: HALLUCINATING; MUSCLE CRAMPS; FEVER 102; TINGLING; SHOOTING/ EXCRUCIATING PAIN; IN BED FOR 2 DAYS; This spontaneous report received from a patient concerned a 35 year old female of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201a21a, and expiry: UNKNOWN) dose was not reported, 1 total, administered on 09-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-JUL-2021, after eight hours of vaccination the patient started experiencing fever 102 F, muscle cramps, chills, hallucinating, and was in bed for 2 days. The patient took warm cloth on forehead to reduce the fever. On an unspecified date in JUL-2021, the patient also experienced tingling and had shooting pain and also had a bad headache. On an unspecified date in JUL-2021, the patient went to ER (emergency room), was hospitalized and ordered MRI (magnetic resonance imaging).The patient was hospitalized for 4 days. It was reported that since the patient had a bad headache so preferred to file the complaint online and also stated not to call health case professional due to pending lab results. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from in bed for 2 days on 11-JUL-2021, had not recovered from fever 102, and shooting pain, and the outcome of muscle cramps, hallucinating and tingling was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20210743704-COVID-19 VACCINE AD26.COV2.S-Hallucinating,Muscle cramps,Tingling,Shooting/Excruciating pain. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).  V0:20210743704-COVID-19 VACCINE AD26.COV2.S-Fever 102. This event(s) is labeled per agency and is therefore considered potentially related.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Pyrexia
Clinical narrative: HALLUCINATING; MUSCLE CRAMPS; FEVER 102; TINGLING; SHOOTING/ EXCRUCIATING PAIN; IN BED FOR 2 DAYS; This spontaneous report received from a patient concerned a 35 year old female of unspecified race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201a21a, and expiry: UNKNOWN) dose was not reported, 1 total, administered on 09-JUL-2021 for prophylactic vaccination. No concomitant medications were reported.  On 09-JUL-2021, after eight hours of vaccination the patient started experiencing fever 102 F, muscle cramps, chills, hallucinating, and was in bed for 2 days. The patient took warm cloth on forehead to reduce the fever. On an unspecified date in JUL-2021, the patient also experienced tingling and had shooting pain and also had a bad headache. On an unspecified date in JUL-2021, the patient went to ER (emergency room), was hospitalized and ordered MRI (magnetic resonance imaging).The patient was hospitalized for 4 days. It was reported that since the patient had a bad headache so preferred to file the complaint online and also stated not to call health case professional due to pending lab results. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from in bed for 2 days on 11-JUL-2021, had not recovered from fever 102, and shooting pain, and the outcome of muscle cramps, hallucinating and tingling was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0:20210743704-COVID-19 VACCINE AD26.COV2.S-Hallucinating,Muscle cramps,Tingling,Shooting/Excruciating pain. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).  V0:20210743704-COVID-19 VACCINE AD26.COV2.S-Fever 102. This event(s) is labeled per agency and is therefore considered potentially related.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident
Clinical narrative: Had a major stroke 6 days after the 2nd vaccine.; This is a spontaneous report received from a contactable female consumer (patient). A 65-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: ER8733) via an unspecified route of administration, in the left arm on 01Apr2021 at 15:15 (at the age of 65-years-old) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EN6206) via an unspecified route of administration, in the left arm on 10Mar2021 at 18:15 (at the age of 65-years-old) as dose 1, single for covid-19 immunisation. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. The patient did not receive any vaccines within four weeks prior to the vaccination. On 07Apr2021 at 07:30, the patient experienced had a major stroke 6 days after the 2nd vaccine. Seriousness criteria was reported hospitalization, disability and life threatening. The adverse event result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient was hospitalized for 43 days. Patient had received treatment for event was stroke protocols TPA (Tissue plasminogen activator), thrombectomy. On 21May2021, the patient underwent lab tests and procedures which included sars-cov-2 test (covid test type post vaccination unknown) result was negative. Outcome of the event was recovering.  Follow up needed, further information has been requested.   On 16Jul2021, follow-up attempts are completed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, SARS-CoV-2 test
Clinical narrative: Had a major stroke 6 days after the 2nd vaccine.; This is a spontaneous report received from a contactable female consumer (patient). A 65-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: ER8733) via an unspecified route of administration, in the left arm on 01Apr2021 at 15:15 (at the age of 65-years-old) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EN6206) via an unspecified route of administration, in the left arm on 10Mar2021 at 18:15 (at the age of 65-years-old) as dose 1, single for covid-19 immunisation. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination the patient had been tested for COVID-19. The patient did not receive any vaccines within four weeks prior to the vaccination. On 07Apr2021 at 07:30, the patient experienced had a major stroke 6 days after the 2nd vaccine. Seriousness criteria was reported hospitalization, disability and life threatening. The adverse event result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient was hospitalized for 43 days. Patient had received treatment for event was stroke protocols TPA (Tissue plasminogen activator), thrombectomy. On 21May2021, the patient underwent lab tests and procedures which included sars-cov-2 test (covid test type post vaccination unknown) result was negative. Outcome of the event was recovering.  Follow up needed, further information has been requested.   On 16Jul2021, follow-up attempts are completed. No further information is expected.
Age: 13.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Moderna was given to 13 years old patient
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Eye pain, Headache, Nausea, Rash
Clinical narrative: FEELING SHIT IN THE PANTS; HEADACHE; DIARRHEA; RASH ON LEFT FOOT AND RIGHT ARM; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non alcohol user, cigarette smoker, grass allergy, bee allergy, mold allergy, dust allergy, and penicillin allergy, and the patient had no medical history. The patient did no drug abuse or illicit drug use. The patient experienced drug allergy when treated with cocaine, and erythromycin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808986, and expiry: UNKNOWN) dose was not reported, administered on 11-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-JUN-2021, the subject experienced rash on left foot and right arm. On 17-JUN-2021, the subject experienced diarrhea. On 18-JUN-2021, the subject experienced headache. On an unspecified date, the subject experienced feeling shit in the pants. Treatment medications (dates unspecified) included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from rash on left foot and right arm, had not recovered from headache, and diarrhea, and the outcome of feeling shit in the pants was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anal incontinence, Diarrhoea, Headache, Rash
Clinical narrative: FEELING SHIT IN THE PANTS; HEADACHE; DIARRHEA; RASH ON LEFT FOOT AND RIGHT ARM; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included non alcohol user, cigarette smoker, grass allergy, bee allergy, mold allergy, dust allergy, and penicillin allergy, and the patient had no medical history. The patient did no drug abuse or illicit drug use. The patient experienced drug allergy when treated with cocaine, and erythromycin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808986, and expiry: UNKNOWN) dose was not reported, administered on 11-JUN-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-JUN-2021, the subject experienced rash on left foot and right arm. On 17-JUN-2021, the subject experienced diarrhea. On 18-JUN-2021, the subject experienced headache. On an unspecified date, the subject experienced feeling shit in the pants. Treatment medications (dates unspecified) included: acetylsalicylic acid. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from rash on left foot and right arm, had not recovered from headache, and diarrhea, and the outcome of feeling shit in the pants was not reported. This report was non-serious.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Angiogram cerebral normal, Anion gap, Aphasia, Arteriogram carotid normal, Blood potassium decreased
Clinical narrative: 40 year old patient received second dose of Moderna lot number 026A21A.  Began to complain of rapid heart beat, tingling, difficulty breathing, difficulty speaking.  No physical evidence of allergic reaction.  Vitals were normal except mild tachycardia.  No rash or wheeze.  Normal oxygen sat.  Watched longer, offered food, but patient continued to state he did not feel right.  At over 1 hour, asked if he would like to drive to ER, but said he could not drive.  Called EMS.  Gave Bendadryl IM (no po in kit).
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram head normal, Confusional state, Dyspnoea, Electrocardiogram, Feeling abnormal
Clinical narrative: 40 year old patient received second dose of Moderna lot number 026A21A.  Began to complain of rapid heart beat, tingling, difficulty breathing, difficulty speaking.  No physical evidence of allergic reaction.  Vitals were normal except mild tachycardia.  No rash or wheeze.  Normal oxygen sat.  Watched longer, offered food, but patient continued to state he did not feel right.  At over 1 hour, asked if he would like to drive to ER, but said he could not drive.  Called EMS.  Gave Bendadryl IM (no po in kit).
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Haematocrit decreased, Haemoglobin increased, Headache, Heart rate increased, Laboratory test
Clinical narrative: 40 year old patient received second dose of Moderna lot number 026A21A.  Began to complain of rapid heart beat, tingling, difficulty breathing, difficulty speaking.  No physical evidence of allergic reaction.  Vitals were normal except mild tachycardia.  No rash or wheeze.  Normal oxygen sat.  Watched longer, offered food, but patient continued to state he did not feel right.  At over 1 hour, asked if he would like to drive to ER, but said he could not drive.  Called EMS.  Gave Bendadryl IM (no po in kit).
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic function test, Paraesthesia, Platelet count normal, SARS-CoV-2 test, Scan with contrast normal
Clinical narrative: 40 year old patient received second dose of Moderna lot number 026A21A.  Began to complain of rapid heart beat, tingling, difficulty breathing, difficulty speaking.  No physical evidence of allergic reaction.  Vitals were normal except mild tachycardia.  No rash or wheeze.  Normal oxygen sat.  Watched longer, offered food, but patient continued to state he did not feel right.  At over 1 hour, asked if he would like to drive to ER, but said he could not drive.  Called EMS.  Gave Bendadryl IM (no po in kit).
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Speech disorder, Tachycardia, White blood cell count normal
Clinical narrative: 40 year old patient received second dose of Moderna lot number 026A21A.  Began to complain of rapid heart beat, tingling, difficulty breathing, difficulty speaking.  No physical evidence of allergic reaction.  Vitals were normal except mild tachycardia.  No rash or wheeze.  Normal oxygen sat.  Watched longer, offered food, but patient continued to state he did not feel right.  At over 1 hour, asked if he would like to drive to ER, but said he could not drive.  Called EMS.  Gave Bendadryl IM (no po in kit).
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Exactly 3 weeks after the second Moderna shot was given the patient developed shingles
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Contusion
Clinical narrative: Severe bruising on right forearm, upper thighs on both right and left legs, back of knees on right and left legs and shins of both legs.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Nausea, Tremor, Vomiting
Clinical narrative: 27yoF without hx of anaphylaxis had acute N/V and shakiness about 10mins after 1st dose of Pfizer vaccine was administered. Vitals 118/74, HR 80s, RR 22. Was speaking fine throughout, w/o any SOB/wheezing or chest pain. Sx were resolved after 10 mins. Had extended monitoring x30 minutes and remained at baseline and was allowed to leave vaccine blitz site. Instructed that 2nd vaccine should be given in Clinic.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong product administered
Clinical narrative: no adverse events. When I enter info in immunization Registry, I notice he got Moderna 1st dose on 1/1/21 and second dose on 1/30/2021 already. He lied that he never got covid vaccine before.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature decreased, Cardiac imaging procedure abnormal, Echocardiogram normal, Electrocardiogram abnormal, Hepatic lesion
Clinical narrative: Dx: Myocarditis  first s/s 02/04/2021 Pt with h/o chronic cardiovascular disease, HTN<  Poissble alternative etiology: possible cardiac sarcoid and T cruzi infection as cause for cMRI findings; these were on the differential in the absence of other definitive cause
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging heart, Myocardial infarction, Myocarditis, SARS-CoV-2 test negative, Sinus bradycardia
Clinical narrative: Dx: Myocarditis  first s/s 02/04/2021 Pt with h/o chronic cardiovascular disease, HTN<  Poissble alternative etiology: possible cardiac sarcoid and T cruzi infection as cause for cMRI findings; these were on the differential in the absence of other definitive cause
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Anion gap normal, Basophil count normal, Blood chloride normal, Blood creatinine normal, Blood glucose normal
Clinical narrative: During cardiac workup for unrelated symptoms, low normal/borderline decreased heart function seen on echo (LVEF 50.7%).  Began treatment with diltiazem.  Began noticing SOB with mild exertion (walking <100 yards) and heartrate stayed above 100bpm despite medication.  Mildly elevated blood pressure.  Followup cardiac MRI performed 7/6 corroborated echo findings (LVEF 52%) and showed patchy areas of subacute pericarditis and myocarditis inflammation with changes to tissue noticed.  Visited urgent care with pericardial chest pain 7/21, received indocin as short term replacement for nabumetone NSAID treatment.  Currently waiting on stress test scheduled for 9/16.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Blood potassium normal, Blood sodium normal, Blood urea normal, C-reactive protein normal, Carbon dioxide normal
Clinical narrative: During cardiac workup for unrelated symptoms, low normal/borderline decreased heart function seen on echo (LVEF 50.7%).  Began treatment with diltiazem.  Began noticing SOB with mild exertion (walking <100 yards) and heartrate stayed above 100bpm despite medication.  Mildly elevated blood pressure.  Followup cardiac MRI performed 7/6 corroborated echo findings (LVEF 52%) and showed patchy areas of subacute pericarditis and myocarditis inflammation with changes to tissue noticed.  Visited urgent care with pericardial chest pain 7/21, received indocin as short term replacement for nabumetone NSAID treatment.  Currently waiting on stress test scheduled for 9/16.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac dysfunction, Cardiac stress test, Chest X-ray normal, Chest pain, Dyspnoea
Clinical narrative: During cardiac workup for unrelated symptoms, low normal/borderline decreased heart function seen on echo (LVEF 50.7%).  Began treatment with diltiazem.  Began noticing SOB with mild exertion (walking <100 yards) and heartrate stayed above 100bpm despite medication.  Mildly elevated blood pressure.  Followup cardiac MRI performed 7/6 corroborated echo findings (LVEF 52%) and showed patchy areas of subacute pericarditis and myocarditis inflammation with changes to tissue noticed.  Visited urgent care with pericardial chest pain 7/21, received indocin as short term replacement for nabumetone NSAID treatment.  Currently waiting on stress test scheduled for 9/16.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram abnormal, Eosinophil count normal, Fibrin D dimer normal, Glomerular filtration rate normal, Haematocrit normal
Clinical narrative: During cardiac workup for unrelated symptoms, low normal/borderline decreased heart function seen on echo (LVEF 50.7%).  Began treatment with diltiazem.  Began noticing SOB with mild exertion (walking <100 yards) and heartrate stayed above 100bpm despite medication.  Mildly elevated blood pressure.  Followup cardiac MRI performed 7/6 corroborated echo findings (LVEF 52%) and showed patchy areas of subacute pericarditis and myocarditis inflammation with changes to tissue noticed.  Visited urgent care with pericardial chest pain 7/21, received indocin as short term replacement for nabumetone NSAID treatment.  Currently waiting on stress test scheduled for 9/16.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Haemoglobin normal, Heart rate increased, Hypertension, Lymphocyte count normal, Magnetic resonance imaging heart
Clinical narrative: During cardiac workup for unrelated symptoms, low normal/borderline decreased heart function seen on echo (LVEF 50.7%).  Began treatment with diltiazem.  Began noticing SOB with mild exertion (walking <100 yards) and heartrate stayed above 100bpm despite medication.  Mildly elevated blood pressure.  Followup cardiac MRI performed 7/6 corroborated echo findings (LVEF 52%) and showed patchy areas of subacute pericarditis and myocarditis inflammation with changes to tissue noticed.  Visited urgent care with pericardial chest pain 7/21, received indocin as short term replacement for nabumetone NSAID treatment.  Currently waiting on stress test scheduled for 9/16.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal, Monocyte count normal, Myocarditis
Clinical narrative: During cardiac workup for unrelated symptoms, low normal/borderline decreased heart function seen on echo (LVEF 50.7%).  Began treatment with diltiazem.  Began noticing SOB with mild exertion (walking <100 yards) and heartrate stayed above 100bpm despite medication.  Mildly elevated blood pressure.  Followup cardiac MRI performed 7/6 corroborated echo findings (LVEF 52%) and showed patchy areas of subacute pericarditis and myocarditis inflammation with changes to tissue noticed.  Visited urgent care with pericardial chest pain 7/21, received indocin as short term replacement for nabumetone NSAID treatment.  Currently waiting on stress test scheduled for 9/16.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Neutrophil count normal, Pericarditis, Platelet count normal, Red blood cell count normal, Red cell distribution width normal
Clinical narrative: During cardiac workup for unrelated symptoms, low normal/borderline decreased heart function seen on echo (LVEF 50.7%).  Began treatment with diltiazem.  Began noticing SOB with mild exertion (walking <100 yards) and heartrate stayed above 100bpm despite medication.  Mildly elevated blood pressure.  Followup cardiac MRI performed 7/6 corroborated echo findings (LVEF 52%) and showed patchy areas of subacute pericarditis and myocarditis inflammation with changes to tissue noticed.  Visited urgent care with pericardial chest pain 7/21, received indocin as short term replacement for nabumetone NSAID treatment.  Currently waiting on stress test scheduled for 9/16.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin I normal, White blood cell count normal
Clinical narrative: During cardiac workup for unrelated symptoms, low normal/borderline decreased heart function seen on echo (LVEF 50.7%).  Began treatment with diltiazem.  Began noticing SOB with mild exertion (walking <100 yards) and heartrate stayed above 100bpm despite medication.  Mildly elevated blood pressure.  Followup cardiac MRI performed 7/6 corroborated echo findings (LVEF 52%) and showed patchy areas of subacute pericarditis and myocarditis inflammation with changes to tissue noticed.  Visited urgent care with pericardial chest pain 7/21, received indocin as short term replacement for nabumetone NSAID treatment.  Currently waiting on stress test scheduled for 9/16.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: developing itching on arm, belly, ear following moderna #2.  given 50mg diphenhydramine with improvement, vitals with normal HR/RR, unable to obtain pulse ox.  patient monitored additional 15 minutes and sent home
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Fatigue, Joint range of motion decreased, Pain in extremity
Clinical narrative: Chest pain, tiredness, arm pain, difficulty lifting arm,
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia oral
Clinical narrative: Patient mentioned that she has been having a reaction that possibly is a side effect from her current medication therapy. Per Spanish translator, she's been getting numbness of the tongue and after she received the vaccine, around 10-13 minutes after, she informed me that she felt that the numbness on her tongue got worse. I asked if her tongue is swollen, her throat tightening and if she has a hard time breathing. She said no. There are no physical signs of anaphylaxis.  I gave her Benadryl and asked her to stay for 15 more minutes. I have been checking her in between her  additional 15mins observation and she says she feels better. She wanted to leave. She mentioned she's a little dizzy before she left.  I informed her that if she feels worse when she gets home, she needs to see a Doctor right away.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Cardiac stress test, Chest X-ray abnormal, Chest discomfort, Chest pain
Clinical narrative: DX: Pericarditis  01/20/2021 S/S: Neck pain, acute chest pain or pressure, Chest pain, more on the left side at the anterior axillary line radiating across the chest while watching a movie occurred previous day and again day of admission while walking.  Possible alternative etiology: Initial concern for ischemia given history (prior MI with stenting, significant residual disease), but pharmacologic stress perfusion study did not show change from prior. One note describes pain reproducible with palpation, raising question of chest wall pain, but not mentioned elsewhere in notes, so appears pericarditis was considered the most likely etiology.  60 year old male with extensive CAD history with new chest pain.  Was hospitalized with new diagnosis of probable pericarditis.  Reported first dose vaccine given 01/14/2021, 4 days prior to initial symptoms. Of note, would not meet case definition for pericarditis (has chest pain but no other finding), but would meet myocarditis case definition (chest pain and troponin elevation); potential myocarditis is not discussed in the clinical notes, perhaps because the troponin elevation was fairly minimal.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Neck pain, Pain, Pericarditis, Troponin normal
Clinical narrative: DX: Pericarditis  01/20/2021 S/S: Neck pain, acute chest pain or pressure, Chest pain, more on the left side at the anterior axillary line radiating across the chest while watching a movie occurred previous day and again day of admission while walking.  Possible alternative etiology: Initial concern for ischemia given history (prior MI with stenting, significant residual disease), but pharmacologic stress perfusion study did not show change from prior. One note describes pain reproducible with palpation, raising question of chest wall pain, but not mentioned elsewhere in notes, so appears pericarditis was considered the most likely etiology.  60 year old male with extensive CAD history with new chest pain.  Was hospitalized with new diagnosis of probable pericarditis.  Reported first dose vaccine given 01/14/2021, 4 days prior to initial symptoms. Of note, would not meet case definition for pericarditis (has chest pain but no other finding), but would meet myocarditis case definition (chest pain and troponin elevation); potential myocarditis is not discussed in the clinical notes, perhaps because the troponin elevation was fairly minimal.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Paraesthesia
Clinical narrative: Patient received second Moderna vaccine at vaccine event.  He had reported some post vaccine tingling with first vaccine, so he was triaged after second vaccine to the 30 minute observation  area.  He again complained of left sided tingling and also subjective numbness of face and tongue.  His exam was normal.  Normal cranial nerve function.  Normal speech. Normal VS.  No meds administered.  Given some snacks.  Symptoms resolved over course of another 30 minutes.  Discharged to home without incident
Sex: F
Vaccine: TDAP
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Infant did not display any abnormal signs or symptoms.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, Bundle branch block left, Chest X-ray abnormal, Chest discomfort, Chest pain
Clinical narrative: DX: Pericarditis S/S: Lethargy/fatigue, Dyspnea on exertion, dyspnea with lying down or orthopnea, edema, anorexia or poor feeding, tachypnea, acute chest pain or pressure Clinician description:3-4 weeks of progressive shortness of breath and dyspnea on exertion.  Typically sleeps propped up on 3 pillows, no new orthopnea or nocturnal dyspnea.  History of sleep apnea but intolerant of CPAP S/S onsetn: 03/26/2021
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dyspnoea, Dyspnoea exertional, Echocardiogram abnormal, Electrocardiogram T wave abnormal
Clinical narrative: DX: Pericarditis S/S: Lethargy/fatigue, Dyspnea on exertion, dyspnea with lying down or orthopnea, edema, anorexia or poor feeding, tachypnea, acute chest pain or pressure Clinician description:3-4 weeks of progressive shortness of breath and dyspnea on exertion.  Typically sleeps propped up on 3 pillows, no new orthopnea or nocturnal dyspnea.  History of sleep apnea but intolerant of CPAP S/S onsetn: 03/26/2021
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Fatigue, Feeding disorder, Left atrial dilatation, Left atrial enlargement
Clinical narrative: DX: Pericarditis S/S: Lethargy/fatigue, Dyspnea on exertion, dyspnea with lying down or orthopnea, edema, anorexia or poor feeding, tachypnea, acute chest pain or pressure Clinician description:3-4 weeks of progressive shortness of breath and dyspnea on exertion.  Typically sleeps propped up on 3 pillows, no new orthopnea or nocturnal dyspnea.  History of sleep apnea but intolerant of CPAP S/S onsetn: 03/26/2021
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Left ventricular dilatation, Lethargy, Oedema, Orthopnoea, Pericardial effusion
Clinical narrative: DX: Pericarditis S/S: Lethargy/fatigue, Dyspnea on exertion, dyspnea with lying down or orthopnea, edema, anorexia or poor feeding, tachypnea, acute chest pain or pressure Clinician description:3-4 weeks of progressive shortness of breath and dyspnea on exertion.  Typically sleeps propped up on 3 pillows, no new orthopnea or nocturnal dyspnea.  History of sleep apnea but intolerant of CPAP S/S onsetn: 03/26/2021
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pericarditis, Respiratory viral panel, SARS-CoV-2 test negative, Sinus rhythm, Sinus tachycardia
Clinical narrative: DX: Pericarditis S/S: Lethargy/fatigue, Dyspnea on exertion, dyspnea with lying down or orthopnea, edema, anorexia or poor feeding, tachypnea, acute chest pain or pressure Clinician description:3-4 weeks of progressive shortness of breath and dyspnea on exertion.  Typically sleeps propped up on 3 pillows, no new orthopnea or nocturnal dyspnea.  History of sleep apnea but intolerant of CPAP S/S onsetn: 03/26/2021
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Tachypnoea, Troponin increased
Clinical narrative: DX: Pericarditis S/S: Lethargy/fatigue, Dyspnea on exertion, dyspnea with lying down or orthopnea, edema, anorexia or poor feeding, tachypnea, acute chest pain or pressure Clinician description:3-4 weeks of progressive shortness of breath and dyspnea on exertion.  Typically sleeps propped up on 3 pillows, no new orthopnea or nocturnal dyspnea.  History of sleep apnea but intolerant of CPAP S/S onsetn: 03/26/2021
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide abnormal, Cardiomegaly, Chest X-ray abnormal, Dyspnoea exertional, Electrocardiogram abnormal
Clinical narrative: DX: Myocarditis S/S: Dyspnea on exertion onset  02/19/2021
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Magnetic resonance imaging abnormal, Myocarditis, SARS-CoV-2 test negative, Troponin abnormal
Clinical narrative: DX: Myocarditis S/S: Dyspnea on exertion onset  02/19/2021
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Bell's palsy, Blood lactate dehydrogenase increased, C-reactive protein normal, Computerised tomogram head normal, Dry eye
Clinical narrative: Patient presented to ED 3/25/21 with right Bell's Palsy.  COVID-19 Positive.  Patient completed COVID-19 vaccinations on 1/12 and 2/2. COVID-19 Infection: #Suspected COVID infection: Onset date: unknown presented with: no symptoms.  Recent exposures: none.   initial CRP: 0.29, LDH: 215 D-dimer: 0.54 -Admit to hospital: contact/droplet precuations -Covid test date:  3/25/21 RA sats: 94% in ER. -empiric abx coverage: none -  No Remdesivir or Dexamethasone for treatment. -  Pt completed both COVID-19 vaccine doses 1/12 and 2/2/21.  Discharge planning Ambulatory O2 challenge daily: Last fever: none Home support for ADLs if needed: YES Medications: 30 day supply   R Bells' Palsy: -  R facial weakness with inability to close his R eye and sparing the forehead. -  Pt also evaluated by Clinic Telestroke and they feel his symptoms are consistent with Bells Palsy. -  CT head negative for acute bleed. -  MRI brain due to complaints of also dysphagia and some dysarthria.   -  Facial weakness seems moderate to severe given above findings as well. -  Lacrilube qHS and Artificial tears q2h PRN dryness R eye -  Prednisone 60mg daily x 7d -  Valacyclovir 1g tid x 7d per protocol.  Dysphagia: -  Could be due to severity of Bells Palsy. -  MRI brain to rule out acute CVA.   -  Speech and swallow eval: mild weakness on mouth on R but normal swallow.  Rec NDDI diet with clears and use of straw on L side of mouth.  DM2: -  A1c: 6.3 this admission. -  Outpatient Meds:  metformin -  CC diet. -  SSI for now.  HTN: -  Continue Norvasc.  BP controlled.  HLD: -  Continue ASA and Atorva.  RAD: -  Continue Advair.  MM: -  Will touch bases with Hematology.  BPH: -  Tamsulosin.  Glaucoma: -  Continue Travatan.  Hosp Issues: CODE STATUS:  FULL CODE Diet: NPO for now DVT Proph:  SCD boots  Disp:  Speech cleared pt stating he has no difficulty swallowing.  If the MRI brain is negative for an acute process, will plan to discharge the patient home today.  Notes: Two patient identifiers confirmed. Patient said that he was doing well without any medical issues and without concerns at this time. This nurs cm reminded patient about mask wearing, social distancing and frequest handwashing. Patient verbalized understanding. F/U Plan: Moderate Risk - 2 week post d/c f/u.  Electronically signed on: Electronically signed on:  2021-03-29